The new process developed by Rice University researchers makes solar cells that are about 10 times more durable than traditional methods. Photos by Jeff Fitlow/Rice University

A groundbreaking Rice University lab has made further strides in its work to make harvesting light energy more efficient and stable.

Presented on the cover of a June issue of Science, a study from Rice engineer Aditya Mohite's lab uncovered a method to synthesize a high-efficiency perovskite solar cell, known as formamidinium lead iodide (FAPbI3), converting them into ultrastable high-quality photovoltaic films, according to a statement from Rice. Photovoltaic films convert sunlight into electricity.

The new process makes solar cells that are about 10 times more durable than traditional methods.

“Right now, we think that this is state of the art in terms of stability,” Mohite said in a statement. “Perovskite solar cells have the potential to revolutionize energy production, but achieving long-duration stability has been a significant challenge.”

The change come from "seasoning" the FAPbI3 with 2D halide perovskites crystals, which the Mohite lab also developed a breakthrough synthesis process for last year

The 2D perovskites helped make the FAPbI3 films more stable. The study showed that films with 2D perovskites deteriorated after two days of generating electricity, while those with 2D perovskites had not started to degrade after 20 days.

“FAPbI3 films templated with 2D crystals were higher quality, showing less internal disorder and exhibiting a stronger response to illumination, which translated as higher efficiency," Isaac Metcalf, a Rice materials science and nanoengineering graduate student and a lead author on the study, said in the statement.

Additionally, researchers say their findings could make developing light-harvesting technologies cheaper, and can also allow light-harvesting panels to be lighter weight and more flexible.

"Perovskites are soluble in solution, so you can take an ink of a perovskite precursor and spread it across a piece of glass, then heat it up and you have the absorber layer for a solar cell,” Metcalf said. “Since you don’t need very high temperatures ⎯ perovskite films can be processed at temperatures below 150 Celsius (302 Fahrenheit) ⎯ in theory that also means perovskite solar panels can be made on plastic or even flexible substrates, which could further reduce costs.”

Mohite adds this has major implications for the energy transition at large.

“If solar electricity doesn’t happen, none of the other processes that rely on green electrons from the grid, such as thermochemical or electrochemical processes for chemical manufacturing, will happen,” Mohite said. “Photovoltaics are absolutely critical.”

The Mohite lab's process for creating 2D perovskites of the ideal thickness and purity was published in Nature Synthesis last fall. At the time, Mohite said the crystals "hold the key to achieving commercially relevant stability for solar cells."

About a year ago, the lab also published its work on developing a scalable photoelectrochemical cell. The research broke records for its solar-to-hydrogen conversion efficiency rate.

———

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”